nodes	percent_of_prediction	percent_of_DWPC	metapath
Brompheniramine—CYP2B6—Raloxifene—osteoporosis	0.0886	0.0943	CbGbCtD
Brompheniramine—CYP2B6—Ethinyl Estradiol—osteoporosis	0.0856	0.091	CbGbCtD
Brompheniramine—CYP2C9—Estropipate—osteoporosis	0.0701	0.0746	CbGbCtD
Brompheniramine—CYP2B6—Cholecalciferol—osteoporosis	0.0684	0.0728	CbGbCtD
Brompheniramine—CYP2C8—Raloxifene—osteoporosis	0.0671	0.0714	CbGbCtD
Brompheniramine—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0648	0.0689	CbGbCtD
Brompheniramine—CYP2C8—Cholecalciferol—osteoporosis	0.0518	0.0551	CbGbCtD
Brompheniramine—CYP2C19—Cholecalciferol—osteoporosis	0.0435	0.0462	CbGbCtD
Brompheniramine—CYP2C8—Estradiol—osteoporosis	0.0418	0.0444	CbGbCtD
Brompheniramine—CYP3A4—Estropipate—osteoporosis	0.0408	0.0434	CbGbCtD
Brompheniramine—CYP3A4—Calcitriol—osteoporosis	0.0408	0.0434	CbGbCtD
Brompheniramine—CYP2C9—Cholecalciferol—osteoporosis	0.0361	0.0384	CbGbCtD
Brompheniramine—CYP2C19—Estradiol—osteoporosis	0.035	0.0373	CbGbCtD
Brompheniramine—CYP2D6—Cholecalciferol—osteoporosis	0.033	0.0352	CbGbCtD
Brompheniramine—CYP3A4—Ergocalciferol—osteoporosis	0.0326	0.0347	CbGbCtD
Brompheniramine—CYP2C9—Estradiol—osteoporosis	0.0291	0.031	CbGbCtD
Brompheniramine—CYP3A4—Raloxifene—osteoporosis	0.0272	0.029	CbGbCtD
Brompheniramine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0263	0.028	CbGbCtD
Brompheniramine—CYP3A4—Cholecalciferol—osteoporosis	0.021	0.0224	CbGbCtD
Brompheniramine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0193	0.0205	CbGbCtD
Brompheniramine—CYP3A4—Estradiol—osteoporosis	0.0169	0.018	CbGbCtD
Brompheniramine—CHRM1—Signaling Pathways—NFATC1—osteoporosis	2.59e-05	0.000431	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—POMC—osteoporosis	2.59e-05	0.000431	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NFATC1—osteoporosis	2.58e-05	0.000429	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—ADCY5—osteoporosis	2.58e-05	0.000429	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—DKK1—osteoporosis	2.58e-05	0.000429	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—DKK1—osteoporosis	2.57e-05	0.000427	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—TPI1—osteoporosis	2.56e-05	0.000427	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—DKK1—osteoporosis	2.56e-05	0.000426	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—ENO1—osteoporosis	2.56e-05	0.000426	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NFATC1—osteoporosis	2.56e-05	0.000425	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—KL—osteoporosis	2.54e-05	0.000423	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—DKK1—osteoporosis	2.54e-05	0.000422	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CYP27A1—osteoporosis	2.53e-05	0.000421	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—IL6R—osteoporosis	2.52e-05	0.00042	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PSMA2—osteoporosis	2.52e-05	0.000419	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PSMA5—osteoporosis	2.52e-05	0.000419	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PGLS—osteoporosis	2.51e-05	0.000418	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GPD2—osteoporosis	2.51e-05	0.000418	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—WNT1—osteoporosis	2.48e-05	0.000413	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—POMC—osteoporosis	2.48e-05	0.000412	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—IDH2—osteoporosis	2.48e-05	0.000412	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—WNT1—osteoporosis	2.47e-05	0.000412	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—WNT1—osteoporosis	2.47e-05	0.00041	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ACP5—osteoporosis	2.46e-05	0.00041	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—IDH2—osteoporosis	2.45e-05	0.000408	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—WNT1—osteoporosis	2.44e-05	0.000406	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.43e-05	0.000404	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—IL6R—osteoporosis	2.42e-05	0.000402	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—FGA—osteoporosis	2.42e-05	0.000402	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—P4HB—osteoporosis	2.41e-05	0.000401	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—FGA—osteoporosis	2.41e-05	0.000401	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—FGA—osteoporosis	2.4e-05	0.000399	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—ADCY5—osteoporosis	2.38e-05	0.000396	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—FGA—osteoporosis	2.38e-05	0.000395	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—ADCY5—osteoporosis	2.37e-05	0.000395	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—GAPDH—osteoporosis	2.37e-05	0.000394	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—ADCY5—osteoporosis	2.37e-05	0.000393	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—ADCY5—osteoporosis	2.34e-05	0.00039	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CYP27A1—osteoporosis	2.33e-05	0.000387	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CYP27A1—osteoporosis	2.31e-05	0.000384	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—RAP1A—osteoporosis	2.3e-05	0.000383	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ATIC—osteoporosis	2.3e-05	0.000382	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PNP—osteoporosis	2.3e-05	0.000382	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—TPI1—osteoporosis	2.29e-05	0.000381	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ACP5—osteoporosis	2.26e-05	0.000377	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PTHLH—osteoporosis	2.25e-05	0.000374	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—BMP2—osteoporosis	2.25e-05	0.000374	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ACP5—osteoporosis	2.24e-05	0.000373	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PTHLH—osteoporosis	2.24e-05	0.000372	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—BMP2—osteoporosis	2.24e-05	0.000372	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PTHLH—osteoporosis	2.23e-05	0.000371	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—BMP2—osteoporosis	2.23e-05	0.000371	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.22e-05	0.000369	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PTHLH—osteoporosis	2.21e-05	0.000368	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—BMP2—osteoporosis	2.21e-05	0.000368	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—ENO1—osteoporosis	2.2e-05	0.000366	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—FGB—osteoporosis	2.2e-05	0.000366	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—FGB—osteoporosis	2.19e-05	0.000364	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—FGB—osteoporosis	2.18e-05	0.000363	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PSMA5—osteoporosis	2.17e-05	0.000361	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PSMA2—osteoporosis	2.17e-05	0.000361	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—FGB—osteoporosis	2.16e-05	0.00036	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—ENO1—osteoporosis	2.16e-05	0.000359	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—P4HB—osteoporosis	2.15e-05	0.000358	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PSMA2—osteoporosis	2.12e-05	0.000353	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PSMA5—osteoporosis	2.12e-05	0.000353	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PSMA2—osteoporosis	2.12e-05	0.000353	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PSMA5—osteoporosis	2.12e-05	0.000353	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PSMA2—osteoporosis	2.11e-05	0.000352	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PSMA5—osteoporosis	2.11e-05	0.000352	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—GAPDH—osteoporosis	2.11e-05	0.000351	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PSMA2—osteoporosis	2.11e-05	0.000351	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PSMA5—osteoporosis	2.11e-05	0.000351	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—TPI1—osteoporosis	2.11e-05	0.00035	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PSMA2—osteoporosis	2.09e-05	0.000347	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PSMA5—osteoporosis	2.09e-05	0.000347	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—TPI1—osteoporosis	2.09e-05	0.000347	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—ADCY5—osteoporosis	2.08e-05	0.000346	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—RAP1A—osteoporosis	2.06e-05	0.000342	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—CYP19A1—osteoporosis	2.05e-05	0.00034	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—SPP1—osteoporosis	2.01e-05	0.000335	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.01e-05	0.000334	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—ADCY5—osteoporosis	1.99e-05	0.000331	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—P4HB—osteoporosis	1.98e-05	0.000329	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CALCA—osteoporosis	1.98e-05	0.000329	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CALCA—osteoporosis	1.97e-05	0.000328	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CALCA—osteoporosis	1.96e-05	0.000327	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—P4HB—osteoporosis	1.96e-05	0.000326	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CA2—osteoporosis	1.95e-05	0.000325	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—OXCT1—osteoporosis	1.95e-05	0.000325	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CALCA—osteoporosis	1.95e-05	0.000324	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—GAPDH—osteoporosis	1.94e-05	0.000323	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—POMC—osteoporosis	1.93e-05	0.000321	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—GAPDH—osteoporosis	1.93e-05	0.00032	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—SPP1—osteoporosis	1.93e-05	0.00032	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—POMC—osteoporosis	1.92e-05	0.00032	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—POMC—osteoporosis	1.92e-05	0.000319	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—MGLL—osteoporosis	1.9e-05	0.000317	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—POMC—osteoporosis	1.9e-05	0.000316	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—RAP1A—osteoporosis	1.89e-05	0.000315	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—RAP1A—osteoporosis	1.88e-05	0.000312	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—ENO1—osteoporosis	1.86e-05	0.00031	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PSMA2—osteoporosis	1.84e-05	0.000305	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PSMA5—osteoporosis	1.84e-05	0.000305	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IRS2—osteoporosis	1.82e-05	0.000303	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—KL—osteoporosis	1.8e-05	0.000299	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.79e-05	0.000298	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—KL—osteoporosis	1.79e-05	0.000298	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—KL—osteoporosis	1.78e-05	0.000297	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—LEP—osteoporosis	1.78e-05	0.000296	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—KL—osteoporosis	1.77e-05	0.000294	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—CYP19A1—osteoporosis	1.76e-05	0.000293	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—POMC—osteoporosis	1.75e-05	0.000291	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—POMC—osteoporosis	1.75e-05	0.00029	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IRS2—osteoporosis	1.74e-05	0.00029	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—POMC—osteoporosis	1.74e-05	0.000289	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—CYP19A1—osteoporosis	1.72e-05	0.000287	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—POMC—osteoporosis	1.72e-05	0.000287	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—IL6R—osteoporosis	1.71e-05	0.000284	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—LEP—osteoporosis	1.7e-05	0.000284	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—IL6R—osteoporosis	1.7e-05	0.000283	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—ESR1—osteoporosis	1.7e-05	0.000283	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—IL6R—osteoporosis	1.7e-05	0.000282	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—IL6R—osteoporosis	1.68e-05	0.00028	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—ADCY5—osteoporosis	1.67e-05	0.000278	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—GPX1—osteoporosis	1.67e-05	0.000277	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ENO1—osteoporosis	1.66e-05	0.000277	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PSMA2—osteoporosis	1.64e-05	0.000273	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PSMA5—osteoporosis	1.64e-05	0.000273	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.64e-05	0.000272	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—ESR1—osteoporosis	1.63e-05	0.000271	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—IDH2—osteoporosis	1.62e-05	0.000269	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IRS1—osteoporosis	1.59e-05	0.000264	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—MTHFR—osteoporosis	1.54e-05	0.000256	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ENO1—osteoporosis	1.53e-05	0.000254	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—POMC—osteoporosis	1.53e-05	0.000254	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.52e-05	0.000253	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IRS1—osteoporosis	1.52e-05	0.000253	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ENO1—osteoporosis	1.52e-05	0.000252	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PSMA5—osteoporosis	1.51e-05	0.000251	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PSMA2—osteoporosis	1.51e-05	0.000251	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PSMA2—osteoporosis	1.49e-05	0.000249	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PSMA5—osteoporosis	1.49e-05	0.000249	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IL6R—osteoporosis	1.49e-05	0.000248	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CYP19A1—osteoporosis	1.49e-05	0.000248	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ACP5—osteoporosis	1.48e-05	0.000246	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IGF1—osteoporosis	1.47e-05	0.000245	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—POMC—osteoporosis	1.46e-05	0.000244	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—ADCY5—osteoporosis	1.44e-05	0.000239	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—GPX1—osteoporosis	1.43e-05	0.000238	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL6R—osteoporosis	1.43e-05	0.000238	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IGF1—osteoporosis	1.41e-05	0.000234	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—ADCY5—osteoporosis	1.41e-05	0.000234	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—ADCY5—osteoporosis	1.41e-05	0.000234	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—GPX1—osteoporosis	1.4e-05	0.000233	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—ADCY5—osteoporosis	1.4e-05	0.000233	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—ADCY5—osteoporosis	1.4e-05	0.000232	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—ADCY5—osteoporosis	1.38e-05	0.00023	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—TPI1—osteoporosis	1.38e-05	0.000229	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—SPP1—osteoporosis	1.36e-05	0.000226	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—SPP1—osteoporosis	1.36e-05	0.000226	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—SPP1—osteoporosis	1.35e-05	0.000225	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—SPP1—osteoporosis	1.34e-05	0.000223	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CYP19A1—osteoporosis	1.33e-05	0.000221	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—MTHFR—osteoporosis	1.32e-05	0.00022	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—MTHFR—osteoporosis	1.29e-05	0.000215	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—P4HB—osteoporosis	1.29e-05	0.000215	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GAPDH—osteoporosis	1.27e-05	0.000211	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—RAP1A—osteoporosis	1.24e-05	0.000206	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IRS2—osteoporosis	1.23e-05	0.000205	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—POMC—osteoporosis	1.23e-05	0.000204	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IRS2—osteoporosis	1.23e-05	0.000204	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.22e-05	0.000203	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IRS2—osteoporosis	1.22e-05	0.000203	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—ADCY5—osteoporosis	1.22e-05	0.000202	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—GPX1—osteoporosis	1.21e-05	0.000202	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CYP19A1—osteoporosis	1.21e-05	0.000202	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IRS2—osteoporosis	1.21e-05	0.000201	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—LEP—osteoporosis	1.2e-05	0.0002	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—LEP—osteoporosis	1.2e-05	0.0002	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—LEP—osteoporosis	1.2e-05	0.000199	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—LEP—osteoporosis	1.18e-05	0.000197	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—ESR1—osteoporosis	1.15e-05	0.000191	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—ESR1—osteoporosis	1.15e-05	0.000191	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—ESR1—osteoporosis	1.14e-05	0.00019	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—ESR1—osteoporosis	1.13e-05	0.000188	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—IL6—osteoporosis	1.12e-05	0.000187	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—MTHFR—osteoporosis	1.12e-05	0.000186	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ADCY5—osteoporosis	1.09e-05	0.000181	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—GPX1—osteoporosis	1.08e-05	0.00018	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—IL6—osteoporosis	1.08e-05	0.000179	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IRS1—osteoporosis	1.07e-05	0.000179	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IRS1—osteoporosis	1.07e-05	0.000178	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IRS1—osteoporosis	1.07e-05	0.000178	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—POMC—osteoporosis	1.06e-05	0.000176	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IRS1—osteoporosis	1.06e-05	0.000176	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—POMC—osteoporosis	1.04e-05	0.000172	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—POMC—osteoporosis	1.03e-05	0.000172	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—POMC—osteoporosis	1.03e-05	0.000172	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—POMC—osteoporosis	1.03e-05	0.000171	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—POMC—osteoporosis	1.02e-05	0.000169	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL6R—osteoporosis	1.01e-05	0.000168	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL6R—osteoporosis	1.01e-05	0.000167	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL6R—osteoporosis	1e-05	0.000167	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ENO1—osteoporosis	1e-05	0.000166	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ADCY5—osteoporosis	9.99e-06	0.000166	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—MTHFR—osteoporosis	9.99e-06	0.000166	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—GPX1—osteoporosis	9.96e-06	0.000166	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IGF1—osteoporosis	9.95e-06	0.000166	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL6R—osteoporosis	9.93e-06	0.000165	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IGF1—osteoporosis	9.92e-06	0.000165	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ADCY5—osteoporosis	9.9e-06	0.000165	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IGF1—osteoporosis	9.89e-06	0.000164	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—GPX1—osteoporosis	9.87e-06	0.000164	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PSMA2—osteoporosis	9.85e-06	0.000164	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PSMA5—osteoporosis	9.85e-06	0.000164	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IGF1—osteoporosis	9.79e-06	0.000163	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—MTHFR—osteoporosis	9.19e-06	0.000153	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—MTHFR—osteoporosis	9.11e-06	0.000152	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—POMC—osteoporosis	8.95e-06	0.000149	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MYC—osteoporosis	8.84e-06	0.000147	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TGFB1—osteoporosis	8.82e-06	0.000147	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MYC—osteoporosis	8.46e-06	0.000141	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TGFB1—osteoporosis	8.44e-06	0.00014	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CYP19A1—osteoporosis	7.99e-06	0.000133	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—POMC—osteoporosis	7.99e-06	0.000133	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—IL6—osteoporosis	7.61e-06	0.000127	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—IL6—osteoporosis	7.58e-06	0.000126	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—IL6—osteoporosis	7.56e-06	0.000126	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—IL6—osteoporosis	7.49e-06	0.000125	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—POMC—osteoporosis	7.35e-06	0.000122	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—POMC—osteoporosis	7.29e-06	0.000121	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IL6—osteoporosis	6.64e-06	0.000111	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ADCY5—osteoporosis	6.53e-06	0.000109	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GPX1—osteoporosis	6.51e-06	0.000108	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL6—osteoporosis	6.36e-06	0.000106	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—MTHFR—osteoporosis	6.01e-06	9.99e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MYC—osteoporosis	5.98e-06	9.95e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TGFB1—osteoporosis	5.96e-06	9.92e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MYC—osteoporosis	5.96e-06	9.91e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TGFB1—osteoporosis	5.95e-06	9.89e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MYC—osteoporosis	5.94e-06	9.88e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TGFB1—osteoporosis	5.93e-06	9.86e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MYC—osteoporosis	5.88e-06	9.79e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TGFB1—osteoporosis	5.87e-06	9.76e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—POMC—osteoporosis	4.8e-06	7.99e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL6—osteoporosis	4.49e-06	7.48e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL6—osteoporosis	4.48e-06	7.45e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL6—osteoporosis	4.47e-06	7.43e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL6—osteoporosis	4.42e-06	7.36e-05	CbGpPWpGaD
